Cite
A multicenter characterization of hepatitis associated with immune checkpoint inhibitors
MLA
Sarah E. Fenton, et al. “A Multicenter Characterization of Hepatitis Associated with Immune Checkpoint Inhibitors.” Oncoimmunology, vol. 10, no. 1, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....350c1b9732fb1b97f8808aae068cbfc4&authtype=sso&custid=ns315887.
APA
Sarah E. Fenton, April K.S. Salama, Sunandana Chandra, Lucy Boyce Kennedy, Georgina V. Long, Akansha Chowdhary, Chanjuan Shi, Daniella E Portal, J. Randall Patrinely, Sara N. Horst, Marisa Palmeri, Janice M. Mehnert, Alexander M. Menzies, Douglas B. Johnson, Meghan J. Mooradian, Jeffrey A. Sosman, Elizabeth A. Scoville, Ryan J. Sullivan, & Ben McGuigan. (2021). A multicenter characterization of hepatitis associated with immune checkpoint inhibitors. Oncoimmunology, 10(1).
Chicago
Sarah E. Fenton, April K.S. Salama, Sunandana Chandra, Lucy Boyce Kennedy, Georgina V. Long, Akansha Chowdhary, Chanjuan Shi, et al. 2021. “A Multicenter Characterization of Hepatitis Associated with Immune Checkpoint Inhibitors.” Oncoimmunology 10 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....350c1b9732fb1b97f8808aae068cbfc4&authtype=sso&custid=ns315887.